Accuracy of self-reported smoking abstinence in clinical trials of hospital-initiated smoking interventions

Addiction

Volumn 112, Issue 12, 2017, Pages 2227-2236

  Scheuermann, Taneisha S ^a   Richter, Kimber P ^a   Rigotti, Nancy A ^b   Cummins, Sharon E ^c   Harrington, Kathleen F ^d   Sherman, Scott E ^e,f   Zhu, Shu Hong ^c   Tindle, Hilary A ^g   Preacher, Kristopher J ^h  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of Alabama at Birmingham   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h VANDERBILT UNIVERSITY   (United States)

Author keywords

Biochemical verification; hospital patients; saliva cotinine; self report; smoking cessation; trials

Indexed keywords

ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HOSPITAL; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROGRAM EVALUATION; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SELF REPORT; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PROGRAM EVALUATION; REPRODUCIBILITY OF RESULTS; SELF REPORT; SMOKING CESSATION; YOUNG ADULT;

EID: 85028429168     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13913     Document Type: Article

References (28)

1. Hughes J. R., Keely J. P., Niaura R. S., Ossip-Klein D. J., Richmond R. L., Swan G. E. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 13–26.
2. West R., Hajek P., Stead L., Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100: 299–303.
3. Conner G. S., Schofield-Hurwitz S., Hardt J., Levasseur G., Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 2009; 11: 12–24.
4. Caraballo R. S., Giovino G. A., Pechacek T. F., Mowery P. D. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: third National Health and Nutrition Examination survey, 1988–1994. Am J Epidemiol 2001; 153: 807–814.
5. West R., Zatonski W., Przewozniak K., Jarvis M. J. Can we trust national smoking prevalence figures? Discrepancies between biochemically assessed and self-reported smoking rates in three countries. Cancer Epidemiol Biomarkers Prev 2007; 16: 820–822.
6. Yeager D. S., Krosnick J. A. The validity of self-reported nicotine product use in the 2001–2008 National Health and Nutrition Examination survey. Med Care; 2010: 1128–1132.
7. Dietz P. M., Homa D., England L. J., Burley K., Tong V. T., Dube S. R. et al. Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am J Epidemiol 2011; 173: 355–359.
8. Pell J. P., Haw S. J., Cobbe S. M., Newby D. E., Pell A. C., Oldroyd K. G. et al. Validity of self-reported smoking status: comparison of patients admitted to hospital with acute coronary syndrome and the general population. Nicotine Tob Res 2008; 10: 861–866.
9. Lewis S. J., Cherry N. M., Mcl Niven R., Barber P. V., Wilde K., Povey A. C. Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic. Biomarkers 2003; 8: 218–228.
10. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4: 149–159.
11. Kim S. Overview of cotinine cutoff values for smoking status classification. Int J Environ Res Public Health 2016; 13: 1236.
12. Aurrekoetxea J. J., Murcia M., Rebagliato M., Lopez M. J., Castilla A. M., Santa-Marina L. et al. Determinants of self-reported smoking and misclassification during pregnancy, and analysis of optimal cut-off points for urinary cotinine: a cross-sectional study. BMJ Open 2013; 3: 1–10.
13. Riley W. T., Stevens V. J., Zhu S. H., Morgan G., Grossman D. Overview of the Consortium of Hospitals Advancing Research on Tobacco (CHART). Trials 2012; 13: 122.
14. Harrington K. F., Kim Y.-I., Chen M., Ramachandran R., Pisu M., Sadasivam R. S. et al. Web-based intervention for transitioning smokers from inpatient to outpatient care: an RCT. Am J Prev Med 2016; 51: 620–629.
15. Rigotti N. A., Regan S., Levy D. E., Japuntich S., Chang Y., Park E. R. et al. Effect of a sustained care intervention on post-discharge smoking cessation among hospitalized adults: a randomized clinical trial. JAMA 2014; 312: 719–728.
16. Sherman S. E., Link A. R., Rogers E. S., Krebs P., Ladapo J. A., Shelley D. R. et al. Smoking-cessation interventions for urban hospital patients: a randomized comparative effectiveness trial. Am J Prev Med 2016; 51: 566–577.
17. Richter K. P., Faseru B., Shireman T. I., Mussulman L. M., Nazir N., Bush T. et al. Warm handoff versus fax referral for linking hospitalized smokers to Quitlines. Am J Prev Med 2016; 51: 587–596.
18. Cummins S. E., Gamst A. C., Brandstein K., Seymann G. B., Klonoff-Cohen H., Kirby C. A. et al. Helping hospitalized smokers: a factorial RCT of nicotine patches and counseling. Am J Prev Med 2016; 51: 578–586.
19. Alterman A. I., Gariti P., Niedbala R. S. Varying results for immunoassay screening kits for cotinine level. Psychol Addict Behav 2002; 16: 256–259.
20. Salimetrics. High Sensitivity Salivary Cotinine Quantitative Enzyme Immunoassay Kit. State College, PA; 2015. Available at: https://www.salimetrics.com/assets/documents/1-2002n.pdf (accessed 21 March 2017) (Archived at http://www.webcitation.org/6p8fI4ePY).
21. Kauffman R. M., Ferketich A. K., Murray D. M., Bellair P. E., Wewers M. E. Measuring tobacco use in a prison population. Nicotine Tob Res 2010; 12: 582–588.
22. Etter J.-F. Financial incentives for smoking cessation in low-income smokers: study protocol for a randomized controlled trial. Trials 2012; 13: 88.
23. Cooper S., Foster K., Naughton F., Leonardi-Bee J., Sutton S., Ussher M. et al. Pilot study to evaluate a tailored text message intervention for pregnant smokers (MiQuit): study protocol for a randomised controlled trial. Trials 2015; 16: 29.
24. Cheung Y. T. D., Leung J. P. K., Cheung C. K. C., Li W. H. C., Wang M. P., Lam T. H. Motivating smokers at outdoor public smoking hotspots to have a quit attempt with a nicotine replacement therapy sample: study protocol for a randomized controlled trial. Trials 2016; 17: 355.
25. Benowitz N. L., Bernert J. T., Caraballo R. S., Holiday D. B., Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009; 169: 236–248.
26. Jarvis M. J., Fidler J., Mindell J., Feyerabend C., West R. Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited. Addiction 2008; 103: 1553–1561.
27. Goniewicz M. L., Eisner M. D., Lazcano-Ponce E., Zielinska-Danch W., Koszowski B., Sobczak A. et al. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-butanol (NNAL) and their Ratio to discriminate active from passive smoking. Nicotine Tob Res 2011; 13: 202–208.
28. Glasgow R. E., Mullooly J. P., Vogt T. M., Stevens V. J., Lichtenstein E., Hollis J. F. et al. Biochemical validation of smoking status: pros, cons, and data from four low-intensity intervention trials. Addict Behav 1993; 18: 511–527.